Skip to main content
. 2025 Aug 23;26:486. doi: 10.1186/s12882-025-04420-9

Table 4.

Summary of the meta-analyses results for the NGAL and ngal/cr measurements

Biomarker Comparison No. of studies Pooled SMD P value Ref.
Urinary NGAL SRNS Vs. SSNS 7 1.889 (0.819 to 2.959) < 0.001 [18, 21, 22, 26, 27, 29, 30]
Urinary NGAL SSNS Vs. healthy controls 5 0.78 (0.434 to 1.128) < 0.001 [18, 21–23, 26]
Urinary NGAL SRNS Vs. healthy controls 4 2.56 (1.152 to 3.971) < 0.001 [18, 21, 22, 26]
NGAL/Cr ratio SRNS Vs. SSNS 3 0.35 (-0.076 to 0.780) 0.107 [28–30]